Original Paper Pancreatology 2005 ; 5 : 370−379 DOI : 10 . 1159 / 000086537 Gene Expression Analysis of Pancreatic Cell Lines Reveals Genes Overexpressed in Pancreatic Cancer Ingo Alldinger a , c , 1 Dag Dittert b , 1 Matthias Peiper c Alberto Fusco d Gennaro Chiappetta e Eike Staub f Matthias Löhr g Ralf Jesenofsky g Gustavo Baretton b Detlef Ockert a Hans - Detlev Saeger a Robert Grützmann a , 2 Christian Pilarsky a , 2 Departments of a Visceral - , Thoracic - and Vascular Surgery , and b Pathology , University Hospital , Dresden , and c Department of General and Visceral Surgery , University Hospital , Düsseldorf , Germany , d Centro di Endocrinologia ed Oncologia Sperimentale del CNR , c / o Dipartimento di Biologia e Patologia Cellulare e Molecolare , Università di Napoli Federico II , Naples , and e Department of Experimental Oncology , Istituto dei Tumori , Naples , Italy , f metaGen Pharmaceuticals , Berlin , and g Medical Department , University Hospital , Mannheim , Germany Received : May 5 , 2004 Accepted after revision : September 16 , 2004 Published online : June 23 , 2005 Dr . Christian Pilarsky Department of Visceral - , Thoracic - and Vascular Surgery University Hospital Dresden , Fetscherstrasse 74 DE – 01307 Dresden ( Germany ) , Tel . + 49 351 458 2246 Fax + 49 351 458 4395 , E - Mail christian . pilarsky @ mailbox . tu - dresden . de ABC Fax + 41 61 306 12 34 E - Mail karger @ karger . ch www . karger . com © 2005 S . Karger AG , Basel and IAP 1424 – 3903 / 05 / 0055 – 0370 $ 22 . 00 / 0 Accessible online at : www . karger . com / pan 1 Authors contributed equally . 2 Authors share senior authorship . Key Words Pancreas W Cancer W Cell line W Primary isolates W Microarray W Thymosin W Immunohistochemistry Abstract Background : Pancreatic cancer is one of the leading causes of cancer - related death . Using DNA gene expres - sion analysis based on a custom made Affymetrix cancer array , we investigated the expression pattern of both pri - mary and established pancreatic carcinoma cell lines . Methods : We analyzed the gene expression of 5 estab - lished pancreatic cancer cell lines ( AsPC - 1 , BxPC - 3 , Ca - pan - 1 , Capan - 2 and HPAF II ) and 5 primary isolates , 1 of them derived from benign pancreatic duct cells . Results : Out of 1 , 540 genes which were expressed in at least 3 experiments , we found 122 genes upregulated and 18 downregulated in tumor cell lines compared to benign cells with a fold change 1 3 . Several of the upregulated genes ( like Prefoldin 5 , ADAM9 and E - cadherin ) have been associated with pancreatic cancer before . The other differentially regulated genes , however , play a so far unknown role in the course of human pancreatic carcino - ma . By means of immunohistochemistry we could show that thymosin ß - 10 ( TMSB10 ) , upregulated in tumor cell lines , is expressed in human pancreatic carcinoma , but not in non - neoplastic pancreatic tissue , suggesting a role for TMSB10 in the carcinogenesis of pancreatic carcino - ma . Conclusion : Using gene expression profiling of pan - creatic cell lines we were able to identify genes differen - tially expressed in pancreatic adenocarcinoma , which might contribute to pancreatic cancer development . Copyright © 2005 S . Karger AG , Basel and IAP Introduction Pancreatic cancer is the fourth leading cause of cancer death in the United States . It can be estimated that annually 28 , 000 people die from pancreatic cancer [ 1 ] . Gene Expression Analysis of Pancreatic Cell Lines Pancreatology 2005 ; 5 : 370−379 371 The incidence has slightly increased over the past de - cades , being 8 . 1 for men and 5 . 4 for women in Germany [ 2 ] . About 80 % of patients with pancreatic carcinoma present with an irresectable tumor at the time of diagno - sis . Chemotherapy and radiation have not been able to increase the survival rate , and curability of the disease strongly depends on early diagnosis . Although several molecular alterations have been associated with pancreat - ic carcinoma , a much larger number of genes are involved in processes leading to cell transformation and , in conse - quence , pancreatic cancer . DNA microarray technology has proven to be a useful tool to screen the differential mRNA expression pattern of normal and carcinoma cells [ 3 – 7 ] . While for other tumor entities a small piece from the tumor can be excised , homogenized and the mRNA extracted to be ana - lyzed , the morphological growth peculiarities of pancreat - ic carcinoma impede this approach . Due to the character - istic host desmoplastic reaction to the tumor , only a small fraction of the mRNA extracted from carcinomatous tumor will descend from the transformed ductal cells . A majority will represent the expression profile of the sur - rounding stromal cells . Cell lines can , however , be used as model systems for tumor development and for the analy - sis of new treatment options . We therefore determined the differential gene expression in pancreatic carcinoma from established tumor cell lines and primary isolates using a custom made Affymetrix GeneChip . Within the set of genes we identified 140 genes as differentially expressed and validated the overexpression of thymosin ß - 10 ( TMSB10 ) within ductal pancreatic adenocarcino - mas by immunohistochemistry . Materials and Methods Cell Lines and RNA Preparation The ATCC ( American Type Culture Collection ) cell lines AsPC - 1 ( CRL - 1682 ) , BxPC - 3 ( CRL - 1687 ) , Capan - 1 ( HTB - 79 ) , Capan - 2 ( HTB - 80 ) and HPAF II ( CRL - 1997 ) were a gift from Dr . M . Schmitz , Institute of Immunology , University of Dresden . UKEAC - 99 was obtained from a patient who underwent Whip - ple’s operation for papillary carcinoma of intermediate differentia - tion [ 8 ] . PI3 was obtained from a metastasis in the omentum of a patient with pancreatic adenocarcinoma of intermediate differentia - tion . PI4 was derived from ascites fluid of a patient with pancreatic adenocarcinoma , and PI5 was obtained from a lung metastasis from a patient with pancreatic adenocarcinoma . All cell lines were tested for tumorigenicity and caused pancreatic adenocarcinoma after injection into mice which were histologically confirmed by a patholo - gist . Chromosomal analysis was performed with all cell lines . ATCC cells and primary isolates were propagated in RPMI 1640 medium ( Gibco ) supplemented with 10 % fetal bovine serum ( Gib - co ) , 2 m M glutamine ( Gibco ) , nonessential amino acids ( 5 ml / l ) , and penicillin / streptomycin ( 10 , 000 units / ml penicillin and 10 mg / ml streptomycin , 10 ml / l medium ; Sigma ) and passaged before con - fluency . The hPDC was obtained from the main pancreatic duct of a patient undergoing surgery for chronic pancreatitis . The cells were propagated in Keratinocyte SFM supplemented with 5 ng / ml EGF , 50 Ì g / ml BPE , 50 Ì g / ml gentamycin , 0 . 25 Ì g / ml Fungizone ; 500 Ì l / 60 mm dish ( Invitrogen , Karlsruhe , Germany ) [ 9 ] . All cells were lysed in a guanidine thiocyanate buffer with 2 % ß - mercaptoethanol added ( Promega , Heidelberg , Germany ) . Poly A + RNA was prepared with a PolyATtract 1000 kit ( Prome - ga ) according to the manufacturer’s recommendations . For each sample the cDNA synthesis and in vitro transcription were per - formed according to the Affymetrix user manual using 500 ng of the isolated RNA . In brief , cDNA synthesis was initiated using the Affy - metrix T7 - oligo - dT promotor - primer combination at 0 . 1 m M . From this first strand cDNA , the second strand synthesis was generated with internal priming . The in vitro transcription was performed with Ambion’s Megascript kit ( Ambion , Huntington , UK ) , as recom - mended by the manufacturer . During the in vitro transcription , bio - tin - labeled nucleotides were incorporated into the aRNA . Hybridiza - tion and detection of the labeled aRNA on the metg001A GeneChip were performed according to Affymetrix’s instructions . Chip Design and Data Analysis The custom metg001A GeneChip used in this study consists of 6 , 117 probe sets resembling 3 , 023 cDNA fragments . The cDNA frag - ments were chosen from a data mining approach to characterize the expression of cancers by an electronic Northern blot [ 10 , 11 ] . In addi - tion genes of signal transduction cascades , which are implicated in cancer development and progression , like the wnt cascade , were selected . The background was computed as the mean of the 2 % darkest feature intensities . After background correction the arrays were nor - malized by dividing each feature of a given GeneChip by the median value derived from all features of the same GeneChip . To generate the representative expression value we used the 75 % quartile of the ranked intensities from the 20 perfect - matching oligonucleotides of a probe set , in an approach similar to that of Irizarry et al . [ 12 ] . To distinguish signal from noise we applied the Wilcoxon signed rank test to each probe set . The probe set was labeled as present if the result of the Wilcoxon signed rank was below 0 . 01 . To determine the relative difference in expression between the tumor cell lines and the benign ductal cells , the mean expression val - ue in the tumor cell lines was calculated and compared to the expres - sion value in the benign ductal cells . Genes were called as differen - tially expressed when the change fold was above 3 and when the gene was called present in at least 3 cell lines as well . Genes are listed according to the difference ratio . Complete linkage clustering of the differentially expressed genes was done using the Genecluster / Treeview software package ( http : / / rana . lbl . gov / EisenSoftware . htm ) using Spearman rank correlation as distance matrix ( fig . 1 ) . Immunohistochemical Staining Tumor tissue was selected from 55 consecutive cases of pancreat - ic ductal adenocarcinoma , whereas adenocarcinoma of the ampulla 372 Pancreatology 2005 ; 5 : 370−379 Alldinger et al . of Vater or the distal ductus choledochus was not included . Patients were operated on at ages from 34 to 80 years ; 27 were male and 28 were female . Four - micron sections were cut from the formalin - fixed , paraffin - embedded , pancreatic adenocarcinoma tissue . The sections were mounted on superfrost slides ( Menzel Gläser , Braunschweig , Germa - ny ) , dewaxed with xylene and gradually hydrated . Antigen was exposed by heating the sections under high pressure in Tris - EDTA - citrate buffer . The primary goat polyclonal anti - human TMSB10 antibody [ 13 ] was diluted 1 : 500 in PBS containing 2 % horse serum ( Vector Laboratories , Burlingame , Calif . , USA ) . After incubation for 45 min , the reaction was visualized with a biotinylated anti - goat anti - body ( 5 Ì g / ml , Vector Laboratories ) and avidin - biotin - peroxidase ( ABC ELITE , Vector Laboratories ) . Diaminobenzidine served as chromogen . Afterwards the slides were briefly counterstained with hematoxylin . The primary antibody was omitted for the negative control . Unspecific goat IgG at the same concentration as the specific Ig were used as isotype controls to assure the specificity of the reac - tion . Staining intensity was evaluated semi - quantitatively as nega - tive , weak , moderate or strong . The final results , however , were recorded as positive or negative staining only . Results Out of the 3 , 023 cDNA fragments interrogated by gene expression profiling 1 , 540 genes were rated as present in at least 3 cell lines . Difference in expression was rated sig - nificant if the ratio was greater than 3 and if the gene was detected as present in at least 3 cell lines as well . Of the 1 , 540 genes , 122 were upregulated and 18 were downregu - lated in respect to the benign cells . Seven genes were upregulated and 3 genes downregulated in primary iso - lates only . One gene was upregulated in ATCC cell lines only and not in primary isolates ( table 1 ) . Using hierarchical clustering , we generated a heat map of the gene expression of the identified genes to visualize the gene expression within each experiment ( fig . 1 ) . Genes encoding proteins of known function have been classified according to functional categories ( fig . 2 ) . Within these categories we found that genes associated with cellular proliferation are commonly upregulated . Within the 122 genes we identified several genes , such as ADAM9 or E - cadherin , with known function in carcinoma of the pan - creas or other tissues ( table 2 ) . Fig . 1 . Hierarchical clustering of differentially expressed genes in pancreatic cells . Black squares indicate that the gene was called absent by the software . Gene Expression Analysis of Pancreatic Cell Lines Pancreatology 2005 ; 5 : 370−379 373 Table 1 . Genes differentially expressed within the pancreatic cell lines analyzed A . Genes upregulated in tumor Name Symbol Unigene ID MV / hPDC BxPC - 3 AsPC - 1 Capan - 1 Capan - 2 HPAF2 PI1 PI3 PI4 PI5 CDC28 protein kinase regulatory subunit 2 CKS2 Hs . 83758 12 . 11 15 . 15 6 . 87 12 . 88 14 . 36 9 . 50 17 . 58 20 . 53 9 . 75 2 . 32 Thymosin ß - 10 TMSB10 Hs . 76293 12 . 08 9 . 47 12 . 60 8 . 83 9 . 40 10 . 13 10 . 89 17 . 13 17 . 88 12 . 40 Similar to transmembrane protein AMIGO3 – Hs . 121520 10 . 13 5 . 88 6 . 84 10 . 03 5 . 67 3 . 52 21 . 84 10 . 11 8 . 60 18 . 69 CSE1 chromosome segregation 1 - like ( yeast ) CSE1L Hs . 90073 9 . 59 5 . 00 8 . 35 6 . 89 8 . 89 6 . 89 11 . 91 19 . 69 13 . 42 5 . 27 Capping protein ( actin filament ) muscle Z - line , · 2 CAPZA2 Hs . 75546 9 . 52 6 . 19 7 . 46 8 . 39 4 . 58 6 . 22 16 . 97 14 . 90 10 . 53 10 . 47 Eukaryotic translation initiation factor 3 , subunit 3 Á , 40 kDa EIF3S3 Hs . 58189 9 . 48 4 . 16 9 . 06 6 . 98 12 . 16 10 . 22 14 . 32 9 . 85 7 . 59 11 . 02 Small nuclear ribonucleoprotein polypeptide G SNRPG Hs . 77496 9 . 39 8 . 33 6 . 89 10 . 82 7 . 54 7 . 71 11 . 25 15 . 11 10 . 69 6 . 17 Prefoldin 5 PFDN5 Hs . 288856 9 . 22 6 . 91 6 . 33 6 . 12 6 . 36 8 . 18 13 . 18 14 . 29 11 . 37 10 . 23 Asparagine synthetase ASNS Hs . 75692 8 . 65 5 . 55 4 . 14 12 . 45 2 . 25 7 . 68 14 . 78 5 . 05 7 . 29 18 . 68 Calmodulin 1 ( phosphorylase kinase , ‰ ) CALM1 Hs . 374441 7 . 91 4 . 89 7 . 19 8 . 80 9 . 57 5 . 45 10 . 59 9 . 17 7 . 83 7 . 70 Proliferating cell nuclear antigen PCNA Hs . 78996 7 . 42 11 . 41 4 . 99 5 . 51 6 . 65 5 . 84 8 . 30 12 . 16 10 . 13 1 . 79 Cyclin - dependent kinase 4 CDK4 Hs . 95577 7 . 35 6 . 64 4 . 81 7 . 07 8 . 95 7 . 57 8 . 43 9 . 53 7 . 69 5 . 46 Dyskeratosis congenita 1 , dyskerin DKC1 Hs . 4747 7 . 24 6 . 04 6 . 28 4 . 94 8 . 05 3 . 23 9 . 70 11 . 38 9 . 12 6 . 39 Zinc finger protein 9 ( a cellular retroviral nucleic - acid - binding protein ) ZNF9 Hs . 2110 7 . 23 8 . 60 5 . 98 5 . 98 6 . 27 5 . 16 9 . 26 8 . 47 6 . 54 8 . 80 Complement component 5 receptor 1 ( C5a ligand ) C5R1 Hs . 2161 7 . 15 0 . 43 11 . 57 1 . 39 17 . 72 5 . 63 12 . 30 10 . 67 4 . 68 NADH dehydrogenase ( ubiquinone ) 1 · subcomplex , 4 , 9 kDa NDUFA4 Hs . 50098 7 . 04 6 . 38 6 . 52 6 . 87 5 . 27 5 . 76 6 . 12 9 . 48 10 . 37 6 . 62 Mitochondrial ribosomal protein L13 MRPL13 Hs . 333823 6 . 93 6 . 04 6 . 46 4 . 39 6 . 08 5 . 42 12 . 74 10 . 33 6 . 50 4 . 40 Profilin 1 PFN1 Hs . 408943 6 . 82 7 . 48 5 . 40 4 . 42 6 . 04 4 . 12 7 . 49 11 . 64 7 . 91 6 . 85 Hypothetical protein MGC40157 MGC40157 Hs . 295362 6 . 67 5 . 98 5 . 82 3 . 44 6 . 86 8 . 44 4 . 14 9 . 00 6 . 10 10 . 26 A disintegrin and metalloproteinase domain 9 ( meltrin Á ) ADAM9 Hs . 2442 6 . 67 4 . 47 7 . 26 5 . 72 5 . 73 10 . 26 4 . 50 9 . 96 6 . 90 5 . 21 Finkel - Biskis - Reilly murine sarcoma virus ( FBR - MuSV ) ubiquitously expressed ( fox derived ) ; ribosomal protein S30 FAU Hs . 177415 6 . 66 6 . 20 4 . 77 6 . 76 4 . 94 5 . 37 5 . 72 9 . 02 10 . 68 6 . 51 PEST - containing nuclear protein PCNP Hs . 71618 6 . 61 5 . 41 5 . 58 3 . 49 4 . 98 3 . 82 9 . 36 12 . 11 9 . 95 4 . 78 Epithelial membrane protein 3 EMP3 Hs . 9999 6 . 59 2 . 73 2 . 69 1 . 24 3 . 08 1 . 59 8 . 94 15 . 04 10 . 72 13 . 24 RAD21 homolog ( S . pombe ) RAD21 Hs . 81848 6 . 58 6 . 22 5 . 27 3 . 99 5 . 94 4 . 27 12 . 34 8 . 84 7 . 38 5 . 01 Ribosomal protein L10a RPL10A Hs . 425293 6 . 50 4 . 14 4 . 72 4 . 85 4 . 82 6 . 89 9 . 70 8 . 22 7 . 47 7 . 72 Isocitrate dehydrogenase 1 ( NADP + ) , soluble IDH1 Hs . 11223 6 . 27 4 . 23 5 . 43 11 . 53 5 . 90 5 . 00 9 . 31 4 . 11 4 . 29 6 . 62 High - mobility group nucleosomal - binding domain 2 HMGN2 Hs . 181163 6 . 18 7 . 59 5 . 22 5 . 45 5 . 21 4 . 46 6 . 86 9 . 06 7 . 35 4 . 43 DEAD / H ( Asp - Glu - Ala - Asp / His ) box polypeptide 39 DDX39 Hs . 311609 6 . 14 3 . 52 4 . 86 5 . 49 7 . 37 2 . 98 8 . 26 11 . 36 7 . 65 3 . 78 NADH dehydrogenase ( ubiquinone ) 1 ß subcomplex , 8 , 19 kDa NDUFB8 Hs . 198273 5 . 90 4 . 88 5 . 00 4 . 28 7 . 50 7 . 08 6 . 32 8 . 96 5 . 35 3 . 67 Fibrillarin FBL Hs . 99853 5 . 77 6 . 28 6 . 84 3 . 79 4 . 29 4 . 88 7 . 59 7 . 08 6 . 91 4 . 27 Proteasome ( prosome . macropain ) subunit , · type , 2 PSMA2 Hs . 411773 5 . 54 3 . 70 3 . 34 4 . 43 3 . 79 4 . 60 8 . 39 9 . 01 7 . 58 5 . 02 Hypothetical protein FLJ14668 FLJ14668 Hs . 334644 5 . 51 5 . 43 4 . 06 4 . 64 3 . 85 4 . 03 5 . 54 8 . 45 8 . 16 5 . 40 Neural precursor cell expressed , developmentally downregulated 5 NEDD5 Hs . 155595 5 . 45 4 . 89 8 . 06 8 . 57 5 . 82 4 . 46 4 . 71 4 . 77 3 . 69 4 . 09 Splicing factor 3b , subunit 1 , 155 kDa SF3B1 Hs . 334826 5 . 35 4 . 15 4 . 76 5 . 56 4 . 28 5 . 35 7 . 03 7 . 03 5 . 93 4 . 07 Ras homolog gene family , member A ARHA Hs . 77273 5 . 25 2 . 14 3 . 96 7 . 55 4 . 38 2 . 56 8 . 40 7 . 53 5 . 10 5 . 60 Apoptosis - related protein APR - 3 APR - 3 Hs . 9527 5 . 23 4 . 00 5 . 43 5 . 89 4 . 29 3 . 92 6 . 72 5 . 99 5 . 02 5 . 83 Triosephosphate isomerase 1 TPI1 Hs . 83848 5 . 21 6 . 16 5 . 27 4 . 36 7 . 60 5 . 08 5 . 54 6 . 73 3 . 82 2 . 34 H1 histone family , member 0 H1F0 Hs . 226117 5 . 20 1 . 46 3 . 87 4 . 69 3 . 14 3 . 35 7 . 37 6 . 39 6 . 41 10 . 15 TAF9 RNA polymerase II , TATA - box - binding protein ( TBP ) - associated Factor , 32 kDa TAF9 Hs . 60679 5 . 17 3 . 16 4 . 53 2 . 64 4 . 94 3 . 43 7 . 89 5 . 98 5 . 22 8 . 79 Thioredoxin - interacting protein TXNIP Hs . 179526 5 . 16 5 . 30 5 . 40 3 . 15 1 . 65 5 . 01 3 . 14 5 . 57 3 . 87 13 . 31 Cytochrome b - 245 , · polypeptide CYBA Hs . 68877 5 . 13 4 . 53 4 . 95 5 . 43 3 . 89 4 . 19 4 . 50 7 . 07 6 . 50 5 . 12 Lymphocyte antigen 6 complex , locus E LY6E Hs . 77667 5 . 13 4 . 96 6 . 29 3 . 91 3 . 70 2 . 68 6 . 75 8 . 91 5 . 29 3 . 64 Similar to S . cerevisiae RER1 RER1 Hs . 40500 5 . 03 2 . 80 5 . 53 3 . 29 3 . 92 3 . 91 6 . 53 9 . 09 5 . 33 4 . 90 Ribosomal protein L4 RPL4 Hs . 286 5 . 01 5 . 27 4 . 65 4 . 96 3 . 55 3 . 82 4 . 11 6 . 39 7 . 68 4 . 68 Cathepsin C CTSC Hs . 10029 5 . 00 4 . 53 3 . 07 2 . 46 6 . 92 4 . 52 7 . 05 6 . 78 6 . 75 2 . 92 Hypoxanthine phosphoribosyltransferase 1 ( Lesch - Nyhan syndrome ) HPRT1 Hs . 82314 4 . 95 5 . 13 2 . 72 3 . 79 2 . 94 3 . 16 8 . 76 8 . 08 6 . 23 3 . 71 Actin - related protein 2 / 3 complex , subunit 1B , 41 kDa ARPC1B Hs . 433506 4 . 94 2 . 49 5 . 62 3 . 84 2 . 47 3 . 24 4 . 82 7 . 59 8 . 92 5 . 48 Annexin A4 ANXA4 Hs . 422986 4 . 92 1 . 70 10 . 68 5 . 50 1 . 09 4 . 99 9 . 05 5 . 36 3 . 63 2 . 27 Cofilin 1 ( nonmuscle ) CFL1 Hs . 180370 4 . 89 4 . 52 2 . 86 3 . 41 4 . 71 3 . 64 6 . 26 9 . 61 5 . 48 3 . 49 Chaperonin - containing TCP1 , subunit 5 ( Â ) CCT5 Hs . 1600 4 . 85 4 . 45 3 . 36 5 . 52 5 . 02 2 . 72 5 . 77 7 . 00 6 . 83 2 . 99 Ribosomal protein L3 RPL3 Hs . 119598 4 . 84 4 . 86 4 . 69 4 . 77 3 . 63 3 . 59 4 . 20 6 . 55 6 . 54 4 . 77 Rho GDP dissociation inhibitor ( GDI ) ß ARHGDIB Hs . 83656 4 . 81 5 . 40 2 . 16 4 . 60 3 . 70 6 . 08 5 . 75 5 . 90 5 . 88 3 . 82 374 Pancreatology 2005 ; 5 : 370−379 Alldinger et al . Table 1 ( continued ) Name Symbol Unigene ID MV / hPDC BxPC - 3 AsPC - 1 Capan - 1 Capan - 2 HPAF2 PI1 PI3 PI4 PI5 Chromosome 15 open reading frame 15 C15orf15 Hs . 284162 4 . 81 4 . 61 2 . 24 6 . 37 2 . 59 4 . 94 7 . 03 4 . 59 4 . 61 6 . 31 unc - 84 homolog A ( C . elegans ) UNC84A Hs . 381143 4 . 76 5 . 66 5 . 57 4 . 02 3 . 36 3 . 86 5 . 99 4 . 03 4 . 87 5 . 48 Siah - interacting protein SIP Hs . 27258 4 . 73 2 . 65 3 . 26 2 . 76 4 . 49 3 . 88 7 . 11 7 . 59 6 . 68 4 . 17 Ribosomal protein , large , P1 RPLP1 Hs . 424299 4 . 71 5 . 14 4 . 60 4 . 84 3 . 51 2 . 83 4 . 06 6 . 37 6 . 48 4 . 62 CGI - 119 protein CGI - 119 Hs . 283670 4 . 70 3 . 29 4 . 24 3 . 48 2 . 09 6 . 03 6 . 65 6 . 33 5 . 45 4 . 70 Programmed cell death 10 PDCD10 Hs . 28866 4 . 53 2 . 96 2 . 32 5 . 44 3 . 86 4 . 32 6 . 17 5 . 84 4 . 67 5 . 15 Adducin 3 ( Á ) ADD3 Hs . 324470 4 . 46 3 . 95 7 . 51 4 . 35 3 . 07 4 . 37 6 . 95 3 . 51 3 . 68 2 . 77 Actin - related protein 2 / 3 complex , subunit 5 , 16 kDa ARPC5 Hs . 82425 4 . 42 3 . 77 2 . 89 3 . 54 3 . 75 2 . 64 5 . 70 7 . 60 5 . 97 3 . 97 Ribosomal protein S13 RPS13 Hs . 165590 4 . 42 4 . 12 4 . 18 4 . 16 3 . 18 3 . 27 3 . 68 5 . 80 7 . 21 4 . 19 Family with sequence similarity 3 , member C FAM3C Hs . 29882 4 . 33 2 . 94 2 . 60 3 . 84 5 . 91 3 . 09 6 . 01 4 . 39 4 . 44 5 . 77 Eukaryotic translation initiation factor 3 , subunit 5 Â , 47 kDa EIF3S5 Hs . 381255 4 . 27 3 . 21 2 . 80 3 . 28 4 . 30 3 . 97 5 . 43 5 . 50 5 . 19 4 . 73 Protein phosphatase 2 ( formerly 2A ) , catalytic subunit , ß isoform PPP2CB Hs . 80350 4 . 23 3 . 84 5 . 62 2 . 67 3 . 37 1 . 72 5 . 55 6 . 23 4 . 23 4 . 82 HMT1 hnRNP methyltransferase - like 2 ( S . cerevisiae ) HRMT1L2 Hs . 20521 4 . 23 4 . 56 3 . 58 3 . 76 3 . 36 3 . 78 3 . 33 5 . 91 5 . 11 4 . 63 Prohibitin PHB Hs . 75323 4 . 20 2 . 42 2 . 66 6 . 85 2 . 70 4 . 05 4 . 91 6 . 41 5 . 45 2 . 36 Chaperonin - containing TCP1 , subunit 8 ( ) CCT8 Hs . 15071 4 . 15 3 . 00 4 . 41 2 . 57 4 . 72 3 . 59 6 . 80 4 . 29 4 . 21 3 . 74 Immediate early response 3 IER3 Hs . 76095 4 . 14 1 . 95 2 . 29 2 . 36 2 . 03 2 . 23 5 . 25 7 . 53 6 . 24 7 . 42 Peroxiredoxin 4 PRDX4 Hs . 83383 4 . 10 3 . 26 5 . 38 3 . 07 4 . 51 3 . 53 5 . 58 5 . 25 3 . 84 2 . 43 Sapiens cDNA : FLJ23477 fis , clone HSI15732 – Hs . 145362 4 . 07 5 . 20 3 . 64 2 . 55 2 . 87 3 . 79 3 . 93 5 . 78 5 . 26 3 . 57 Heterogeneous nuclear ribonucleoprotein K HNRPK Hs . 129548 4 . 06 2 . 55 3 . 70 3 . 81 3 . 83 3 . 12 5 . 42 5 . 42 4 . 40 4 . 33 MCM7 minichromosome maintenance deficient 7 ( S . cerevisiae ) MCM7 Hs . 77152 4 . 03 4 . 32 2 . 58 5 . 79 3 . 69 3 . 74 4 . 72 4 . 96 4 . 27 2 . 20 – EST 3 . 95 4 . 04 4 . 16 2 . 30 3 . 12 2 . 75 3 . 64 5 . 69 5 . 69 4 . 15 Membranecofactor protein ( CD46 , trophoblast - lymphocyte cross - reactive antigen ) MCP Hs . 83532 3 . 94 4 . 10 3 . 10 3 . 85 4 . 53 4 . 52 5 . 34 3 . 85 2 . 85 3 . 33 Mitochondrial ribosomal protein L42 MRPL42 Hs . 112110 3 . 91 3 . 17 1 . 89 4 . 70 2 . 65 3 . 19 5 . 42 6 . 00 4 . 18 3 . 95 Heat shock 70 kDa protein 8 HSPA8 Hs . 180414 3 . 90 3 . 46 4 . 79 2 . 91 3 . 39 3 . 71 4 . 34 4 . 66 3 . 40 4 . 46 NADH dehydrogenase ( ubiquinone ) 1 ß subcomplex , 9 , 22 kDa NDUFB9 Hs . 15977 3 . 89 2 . 62 2 . 74 4 . 36 2 . 91 2 . 76 5 . 23 5 . 56 5 . 12 3 . 70 Ribosomal protein L7 RPL7 Hs . 153 3 . 85 2 . 22 3 . 56 3 . 62 3 . 15 3 . 35 3 . 66 5 . 57 5 . 46 4 . 10 Dynein , cytoplasmic , light polypeptide 2A DNCL2A Hs . 100002 3 . 77 2 . 36 4 . 93 2 . 56 4 . 09 2 . 96 2 . 95 4 . 57 4 . 03 5 . 51 Matrin 3 MATR3 Hs . 78825 3 . 76 2 . 79 3 . 79 2 . 57 2 . 90 3 . 21 5 . 08 5 . 33 4 . 36 3 . 82 Lysosomal - associated protein transmembrane 4 · LAPTM4A Hs . 111894 3 . 74 2 . 50 6 . 00 3 . 71 3 . 11 3 . 68 4 . 36 3 . 58 2 . 94 3 . 83 KIAA0152 gene product KIAA0152 Hs . 181418 3 . 73 3 . 18 4 . 21 3 . 72 2 . 47 2 . 43 5 . 42 5 . 34 4 . 46 2 . 34 BUB3 budding uninhibited by benzimidazoles 3 homolog ( yeast ) BUB3 Hs . 40323 3 . 72 3 . 45 1 . 81 2 . 30 4 . 02 4 . 06 5 . 36 5 . 85 4 . 28 2 . 34 Tubulin - specific chaperone a TBCA Hs . 433254 3 . 71 1 . 81 2 . 84 2 . 14 2 . 40 2 . 54 6 . 13 5 . 76 5 . 90 3 . 83 Ras - related C3 botulinum toxin substrate 1 ( rho family , small GTP - binding protein Rac1 ) RAC1 Hs . 173737 3 . 67 2 . 20 3 . 04 1 . 96 2 . 76 1 . 90 4 . 90 5 . 30 5 . 16 5 . 76 TERA protein TERA Hs . 180780 3 . 66 2 . 14 2 . 97 1 . 48 2 . 26 3 . 02 5 . 27 5 . 54 4 . 90 5 . 33 Farnesyl diphosphate synthase ( farnesyl pyrophosphate synthetase , dimethylallyl - transtransferase , geranyltranstransferase ) FDPS Hs . 335918 3 . 65 3 . 54 2 . 24 4 . 30 6 . 03 4 . 63 3 . 73 2 . 61 3 . 00 2 . 74 Poly ( rC ) - binding protein 2 PCBP2 Hs . 63525 3 . 64 3 . 72 3 . 35 2 . 38 3 . 78 4 . 39 3 . 71 4 . 43 3 . 51 3 . 46 Cytochrome C oxidase subunit VIc COX6C Hs . 351875 3 . 59 3 . 35 2 . 74 2 . 29 3 . 49 3 . 27 4 . 71 5 . 28 4 . 39 2 . 84 APEX nuclease ( multifunctional DNA repair enzyme ) 1 APEX1 Hs . 73722 3 . 59 2 . 45 2 . 12 2 . 46 3 . 08 3 . 70 4 . 68 5 . 45 4 . 77 3 . 56 ATPase , H + transporting , lysosomal 21 kDa , V0 subunit c ATP6V0B Hs . 7476 3 . 57 3 . 59 2 . 85 5 . 19 5 . 20 3 . 01 2 . 73 4 . 10 2 . 70 2 . 76 EST 3 . 57 0 . 00 1 . 52 0 . 00 3 . 15 5 . 51 6 . 73 4 . 52 4 . 95 5 . 73 Hypothetical protein MGC14151 MGC14151 Hs . 333414 3 . 54 2 . 67 2 . 53 4 . 19 3 . 22 4 . 41 3 . 97 4 . 79 4 . 51 1 . 59 Cathepsin B CTSB Hs . 297939 3 . 53 2 . 61 5 . 75 1 . 95 2 . 83 2 . 87 3 . 28 4 . 19 3 . 80 4 . 50 Prostatic - binding protein PBP Hs . 80423 3 . 52 2 . 79 3 . 35 2 . 71 2 . 12 3 . 20 4 . 40 6 . 36 4 . 17 2 . 57 Stathmin 1 / oncoprotein 18 STMN1 Hs . 406269 3 . 51 2 . 19 3 . 72 2 . 57 2 . 60 1 . 66 3 . 58 6 . 87 6 . 03 2 . 38 Activated RNA polymerase II transcription cofactor 4 PC4 Hs . 349506 3 . 50 2 . 76 1 . 81 3 . 25 2 . 41 3 . 60 4 . 04 5 . 67 4 . 30 3 . 69 NADH dehydrogenase ( ubiquinone ) 1 ß subcomplex , 4 , 15 kDa NDUFB4 Hs . 227750 3 . 50 3 . 24 2 . 62 3 . 05 3 . 98 3 . 98 4 . 11 4 . 17 3 . 43 2 . 93 Uncharacterized hypothalamus protein HT007 HT007 Hs . 24371 3 . 50 3 . 47 1 . 65 3 . 87 2 . 82 3 . 08 4 . 95 4 . 24 4 . 09 3 . 33 Proteasome ( prosome . macropain ) subunit , · type , 6 PSMA6 Hs . 410276 3 . 50 3 . 66 2 . 30 4 . 30 1 . 58 2 . 97 3 . 56 5 . 09 5 . 14 2 . 87 ATPsynthase , H + transporting , mitochondrial F0 complex , subunit d ATP5H Hs . 49018 3 . 46 2 . 15 2 . 13 1 . 96 3 . 15 3 . 32 5 . 50 5 . 35 4 . 39 3 . 17 Barrier to autointegration factor 1 BANF1 Hs . 433759 3 . 44 3 . 93 2 . 13 2 . 66 2 . 62 3 . 24 4 . 55 5 . 77 3 . 18 2 . 91 Stearoyl - CoA desaturase ( ‰ - 9 - desaturase ) SCD Hs . 119597 3 . 44 5 . 59 2 . 76 3 . 28 3 . 96 2 . 82 3 . 84 3 . 19 3 . 00 2 . 51 Chaperonin - containing TCP1 , subunit 6A ( ˙ ) CCT6A Hs . 82916 3 . 42 2 . 73 2 . 40 3 . 11 2 . 81 2 . 36 4 . 46 4 . 98 4 . 11 3 . 77 Gene Expression Analysis of Pancreatic Cell Lines Pancreatology 2005 ; 5 : 370−379 375 Table 1 ( continued ) Name Symbol Unigene ID MV / hPDC BxPC - 3 AsPC - 1 Capan - 1 Capan - 2 HPAF2 PI1 PI3 PI4 PI5 Interferon , · - inducible protein ( clone IFI - 15K ) G1P2 Hs . 432233 3 . 41 2 . 95 4 . 58 3 . 91 5 . 27 3 . 73 2 . 29 3 . 22 2 . 57 2 . 15 Peroxiredoxin 5 PRDX5 Hs . 31731 3 . 39 3 . 36 2 . 17 2 . 47 2 . 33 2 . 85 3 . 89 5 . 17 4 . 12 4 . 12 ATPsynthase , H + transporting , mitochondrial F0 complex , subunit f , isoform 2 ATP5J2 Hs . 235557 3 . 36 4 . 04 1 . 31 4 . 50 3 . 62 3 . 87 4 . 48 3 . 96 2 . 90 1 . 59 Ribosomal protein S9 RPS9 Hs . 180920 3 . 33 3 . 34 3 . 11 3 . 23 2 . 31 2 . 52 2 . 68 4 . 22 5 . 49 3 . 05 X - ray repair complementing defective repair in Chinese hamster cells 5 ( double - strand - break rejoining ; Ku autoantigen , 80 kDa ) XRCC Hs . 84981 3 . 29 1 . 88 2 . 91 2 . 26 3 . 00 2 . 26 5 . 36 5 . 03 3 . 90 3 . 02 Chromosome 20 open reading frame 43 C20orf43 Hs . 182281 3 . 29 3 . 69 3 . 15 2 . 99 3 . 03 2 . 89 3 . 08 4 . 21 3 . 15 3 . 43 Glioma tumor suppressor candidate region gene 2 GLTSCR2 Hs . 421907 3 . 28 2 . 88 3 . 91 1 . 89 2 . 42 2 . 68 3 . 55 3 . 42 4 . 19 4 . 55 Small nuclear ribonucleoprotein D2 polypeptide 16 . 5 kDa SNRPD2 Hs . 424327 3 . 25 3 . 27 3 . 06 3 . 13 2 . 35 2 . 59 2 . 76 4 . 24 5 . 06 2 . 83 Defender against cell death 1 DAD1 Hs . 82890 3 . 24 3 . 09 2 . 87 2 . 70 3 . 13 3 . 59 3 . 98 3 . 95 2 . 59 3 . 30 Protein disulfide isomerase - related protein P5 Hs . 182429 3 . 24 1 . 98 3 . 73 2 . 83 2 . 80 3 . 16 4 . 71 4 . 27 3 . 04 2 . 67 Cell death - regulatory protein GRIM19 GRIM19 Hs . 279574 3 . 23 2 . 39 2 . 75 2 . 88 2 . 60 2 . 19 4 . 07 6 . 15 3 . 45 2 . 60 Death - associated protein 3 DAP3 Hs . 159627 3 . 17 2 . 19 1 . 52 2 . 54 2 . 98 2 . 54 3 . 42 5 . 04 4 . 62 3 . 71 Inorganic pyrophosphatase 2 PPA2 Hs . 5123 3 . 17 3 . 79 1 . 86 3 . 20 2 . 56 2 . 93 4 . 30 4 . 06 3 . 93 1 . 89 Poly ( A ) - binding protein , cytoplasmic 1 PABPC1 Hs . 172182 3 . 16 2 . 73 2 . 82 2 . 81 3 . 30 2 . 72 3 . 96 3 . 17 3 . 24 3 . 65 Ribosomal protein L13 RPL13 Hs . 431392 3 . 14 3 . 33 2 . 95 3 . 13 2 . 24 2 . 44 2 . 59 4 . 08 4 . 56 2 . 96 Guanine - nucleotide - binding protein ( G protein ) , Á 12 GNG12 Hs . 8107 3 . 13 2 . 81 3 . 22 2 . 23 2 . 40 3 . 71 4 . 11 3 . 53 3 . 32 2 . 84 CDC10 cell division cycle 10 homolog ( S . cerevisiae ) CDC10 Hs . 184326 3 . 10 2 . 68 2 . 38 1 . 95 2 . 42 2 . 45 4 . 84 4 . 53 3 . 85 2 . 82 Anaplastic lymphoma kinase ( Ki - 1 ) ALK Hs . 9614 3 . 10 2 . 49 2 . 67 2 . 21 2 . 49 2 . 51 3 . 80 4 . 89 4 . 09 2 . 77 B . Genes downregulated in tumor cell lines Name Symbol Unigene ID MV / hPDC BxPC - 3 AsPC - 1 Capan - 1 Capan - 2 HPAF2 PI1 PI3 PI4 PI5 Thrombospondin 1 THBS1 Hs . 87409 0 . 31 0 . 60 0 . 10 0 . 13 0 . 52 0 . 29 0 . 30 0 . 22 0 . 33 Leucine - rich repeat - containing 8 LRRC8 Hs . 173484 0 . 31 0 . 51 0 . 22 0 . 48 0 . 20 0 . 24 0 . 25 0 . 29 0 . 29 Phosphoprotein enriched in astrocytes 15 PEA15 Hs . 194673 0 . 29 0 . 24 0 . 19 0 . 26 0 . 32 0 . 21 0 . 21 0 . 38 0 . 40 0 . 40 Coatomer protein complex , subunit · COPA Hs . 75887 0 . 29 0 . 25 0 . 25 0 . 32 0 . 24 0 . 30 0 . 32 0 . 32 0 . 31 0 . 31 Sapiens cDNA FLJ11812 fis , clone HEMBA1006364 Hs . 23837 0 . 28 0 . 21 0 . 28 0 . 49 0 . 29 0 . 21 0 . 26 0 . 28 0 . 21 Ets homologous factor EHF Hs . 182339 0 . 28 0 . 31 0 . 26 0 . 26 0 . 20 0 . 32 0 . 27 0 . 30 0 . 29 0 . 30 Dual specificity phosphatase 1 DUSP1 Hs . 171695 0 . 27 0 . 11 0 . 28 0 . 09 0 . 10 0 . 10 0 . 16 0 . 21 0 . 41 0 . 94 Tubulin , · 3 TUBA3 Hs . 433394 0 . 25 0 . 12 0 . 12 0 . 10 0 . 35 0 . 37 0 . 42 Small nuclear ribonucleoprotein polypeptide N SNRPN Hs . 48375 0 . 24 0 . 22 0 . 12 0 . 50 0 . 33 0 . 13 0 . 15 Zinc finger protein 217 ZNF217 Hs . 155040 0 . 23 0 . 24 0 . 24 0 . 24 0 . 14 0 . 20 0 . 24 0 . 25 0 . 31 Hypothetical protein BM - 002 BM - 002 Hs . 367646 0 . 23 0 . 32 0 . 09 0 . 21 0 . 24 0 . 22 0 . 29 Amphiregulin ( schwannoma - derived growth factor ) AREG Hs . 270833 0 . 20 0 . 24 0 . 21 0 . 14 0 . 16 0 . 20 0 . 18 0 . 24 Cyclin - dependent kinase inhibitor 1A ( p21 , Cip1 ) CDKN1A Hs . 179665 0 . 17 0 . 16 0 . 12 0 . 14 0 . 14 0 . 10 0 . 08 0 . 19 0 . 21 0 . 39 CCR4 - NOT transcription complex , subunit 7 CNOT7 Hs . 380963 0 . 17 0 . 19 0 . 12 0 . 13 0 . 18 0 . 15 0 . 16 0 . 22 0 . 18 0 . 15 Serine ( or cysteine ) proteinase inhibitor , clade B ( ovalbumin ) , member 2 SERPINB2 Hs . 75716 0 . 13 0 . 71 0 . 03 0 . 03 0 . 05 0 . 03 0 . 04 0 . 04 Serum amyloid A1 SAA1 Hs . 332053 0 . 12 0 . 10 0 . 11 0 . 15 Hypothetical protein FLJ10154 FLJ10154 Hs . 179972 0 . 10 0 . 10 0 . 07 0 . 07 0 . 06 0 . 06 0 . 12 0 . 17 0 . 16 0 . 10 KIAA0669 gene product KIAA0669 Hs . 52526 0 . 07 0 . 04 0 . 05 0 . 05 0 . 07 0 . 07 0 . 07 0 . 10 C . Genes upregulated in primary isolates only Name Symbol Unigene ID MV all / hPDC MV ATCC / hPDC MV PI / hPDC BxPC - 3 AsPC - 1 Capan - 1 Capan - 2HPAF PI1 PI3 PI4 PI5 Importin 7 IPO7 Hs . 5151 2 . 31 1 . 51 3 . 11 1 . 90 1 . 25 1 . 25 1 . 63 3 . 33 3 . 22 3 . 37 2 . 52 Hypothetical protein DKFZp434L142 DKFZp434L142 Hs . 323583 2 . 23 0 . 95 3 . 52 0 . 81 0 . 95 1 . 16 0 . 87 4 . 94 4 . 68 3 . 37 1 . 08 Transmembrane 4 superfamily member 7 TM4SF7 Hs . 26518 3 . 12 1 . 90 4 . 03 1 . 86 2 . 07 1 . 76 2 . 31 5 . 57 4 . 04 4 . 20 Insulin - like - growth - factor - binding protein 6 IGFBP6 Hs . 274313 3 . 34 2 . 18 4 . 50 5 . 89 0 . 87 0 . 81 1 . 15 5 . 44 4 . 80 3 . 74 4 . 02 Chromosome 8 open reading frame 4 C8orf4 Hs . 283683 3 . 32 0 . 88 4 . 53 0 . 43 1 . 34 1 . 07 2 . 96 3 . 62 10 . 49 Insulin - like - growth - factor - binding protein 3 IGFBP3 Hs . 77326 5 . 29 1 . 68 8 . 89 2 . 87 1 . 93 1 . 08 0 . 84 6 . 25 9 . 80 12 . 39 7 . 12 Vimentin VIM Hs . 297753 5 . 21 1 . 25 9 . 17 0 . 34 3 . 70 0 . 63 0 . 34 6 . 60 10 . 34 12 . 25 7 . 51 376 Pancreatology 2005 ; 5 : 370−379 Alldinger et al . Table 1 ( continued ) D . Genes downregulated in primary isolates only Name Symbol Unigene ID MV all / hPDC MV ATCC / hPDC MV PI / hPDC BxPC - 3 AsPC - 1 Capan - 1 Capan - 2 HPAF2 PI1 PI3 PI4 PI5 CD24 antigen CD24 Hs . 375108 0 . 41 0 . 59 0 . 03 0 . 70 0 . 38 0 . 89 0 . 40 0 . 03 0 . 03 0 . 02 Secretory leukocyte protease Inhibitor ( antileukoproteinase ) SLPI Hs . 251754 0 . 56 0 . 79 0 . 28 0 . 79 0 . 94 1 . 07 0 . 41 0 . 71 0 . 56 0 . 15 0 . 13 0 . 27 Cadherin 1 , E - cadherin CDH1 Hs . 194657 0 . 58 0 . 83 0 . 28 1 . 11 0 . 65 1 . 00 0 . 79 0 . 59 0 . 49 0 . 17 0 . 20 0 . 25 E . Genes upregulated in ATCC cell lines only Name Symbol Unigene ID MV all / hPDC MV ATCC / hPDC MV PI / hPDC BxPC - 3 AsPC - 1 Capan - 1 Capan - 2 HPAF2 PI1 PI3 PI4 PI5 Frizzled 6 FZD6 Hs . 114218 3 . 12 3 . 55 1 . 25 6 . 62 3 . 97 3 . 90 3 . 88 3 . 75 1 . 64 0 . 87 1 . 11 1 . 37 The fold change of expression of the tumor cell lines vs . the cell line hPDC . MV / hPDC = fold change of the mean of the expression value of the tumor cell lines vs . hPDC . Fig . 2 . Functional categories of differential - ly expressed genes . Numbers above the bars indicate the number of genes within the group . 60 50 40 30 20 10 0 C e ll s t r u c t u r e C e ll p r o li f e r a t i on S i gn a l t r a n s du c t i on m R N A p r o c e ss i ng A pop t o s i s En z y m e s O n c og e n e s O t h e r U n k no w n 30 14 8 8 5 4 1 28 53 Overexpression of TMSB10 in Human Pancreatic Carcinoma Expression changes observed in cell lines are not neces - sarily represented in primary tissues also . Therefore , out of the 122 upregulated genes we selected TMSB10 to analyze the expression of its protein in human pancreatic adenocar - cinoma by using a polyclonal antibody and immunohisto - chemistry . Moreover , TMSB10 is associated with cellular proliferation in a number of cancers indicating that overex - pression of this gene might be a causal event [ 13 ] . TMSB10 expression was detected in endothelium , smooth muscle cells , neuronal cells , and strongly in mac - rophages , both in tumor and in normal tissues . In 49 of the 54 ( 90 . 7 % ) ductal adenocarcinomas examined , immu - noreactivity for TMSB10 was detected in the tumor cells ( fig . 3 ) . Conversely , in none of the 10 sections of normal pancreatic tissue could TMSB10 be shown by means of immunohistochemistry . In 24 of 54 ( 44 . 4 % ) cases , we detected staining in the stroma . The correlation between staining in the tumor and staining in stroma cells , which Gene Expression Analysis of Pancreatic Cell Lines Pancreatology 2005 ; 5 : 370−379 377 Fig . 3 . Immunohistochemical staining of non - neoplastic pancreas ( A ) , ductal pancreatic adenocarcinoma ( B ) and stromal tissue within a pancreatic adenocarcinoma ( C ) using TMSB10 antibody . Examples for normal ducts ( d ) , endothelial cells ( e ) and stromal cells ( s ) are indicated with arrows . The pancreatic adenocarcinoma B was scored as 2 + and the sample C as 3 + . A , B 100 ! , C 200 ! magnification . D – F Strong ( D ) , moderate ( E ) and weak ( F ) staining of pancreatic adenocarcinoma samples . Table 2 . Genes known to be involved in tumorigenesis in various tissues Name Symbol Unigene ID Function Involved in cancer Involved in pancreatic cancer Reference Prefoldin 5 PFDN5 Hs . 288856 Chaperone Yes [ 25 ] Thymosin ß - 10 TMSB10 Hs . 76293 Proliferation Yes [ 13 , 22 , 23 ] Calmodulin 1 CALM1 Hs . 374441 Signal transduction Yes No [ 26 ] Cellular apoptosis susceptibility protein CSE1L / CAS CSE1L Hs . 90073 Proliferation and apoptosis Yes No [ 27 ] Lymphocyte antigen 6 LY6E Hs . 77667 Signal transduction Yes No [ 28 ] Cyclin - dependent kinase 4 CDK4 Hs . 95577 Cell cycle Yes No [ 29 ] ADAM9 ADAM9 Hs . 2442 Proliferation Yes Yes [ 30 ] Prohibitin PHB Hs . 75323 Proliferation Yes No [ 31 ] Cyclin - dependent kinase inhibitor 1 CDKN1A Hs . 179665 Apoptosis Yes No [ 32 ] E - cadherin CDH1 Hs . 194657 Cell adhesion Yes Yes [ 16 , 18 , 33 , 34 ] Table 3 . TMSB10 protein expression in pancreatic ductal adenocar - cinoma cells ( n = 55 ) and in stroma cells within the tumors Tumor positive Tumor negative Stroma positive 20 2 Stroma negative 28 5 p = 0 . 411 , Fisher’s exact test . was not significant , is shown in table 3 . Furthermore , we could not find a significant correlation between the posi - tivity or the intensity of expression of TMSB10 and post - operative survival of patients . However , we observed that TMSB10 is highly expressed within well - and poorly - dif - ferentiated carcinomas ( G1 and G3 ) , whereas the majori - ty of moderately differentiated tumors ( G2 ) expressed TMSB10 only moderately . 378 Pancreatology 2005 ; 5 : 370−379 Alldinger et al . Discussion The DNA microarray technology is widely used as a powerful tool to investigate the mRNA expression pattern of various tissues and cell types . For tissues that are diffi - cult to access or scarcely available , cell lines are a helpful alternative . This is especially true for pancreatic cancer . It is well known that cells change both their morphology and their expression pattern when isolated from their parent organism , the human body [ 14 , 15 ] . However , analysis of cell lines might circumvent the need for microdissection of tissues and , furthermore , allow the characterization of the most adequate model system for further analysis of differentially expressed genes . Upregulation of growth factors , cytokines , receptors , extracellular matrix proteins and numerous other pro - teins is a common event in carcinogenesis . We corrobo - rated this in the pancreatic tumor cell lines analyzed in this study , finding 122 genes upregulated and only 18 downregulated in respect to benign cells . Apart from the genes differentially regulated in all cell lines , we found 7 genes upregulated and 3 genes downreg - ulated in the primary isolates only , while 1 gene , frizzled 6 , was upregulated only in the ATCC cell lines . E - cadher - in , 1 of the 3 genes downregulated in primary cells , is the main adhesion molecule of epithelia , and it has been implicated in carcinogenesis because it is frequently lost in human epithelial cancers [ 16 ] . It is known to act as a strong invasion suppressor in experimental tumor cell sys - tems [ 17 ] . Partial or complete loss of E - cadherin expres - sion correlates with malignancy in human cancers [ 18 ] . Interestingly , we found downregulation in the primary isolates , but not in the ATCC cells , which may support the assumption that primary cell lines reflect the biological features of the tumor more than established cell lines . The mesenchymal intermediate filament marker vi - mentin is strongly expressed in invasive pancreatic carci - nomas [ 19 ] and generally expressed in pancreatic carcino - ma cell lines [ 20 ] . The overexpression in primary isolates suggests a relative importance of this filament in cells adapting to the new environment petridish ; it seems to be of less importance after adjustment to the different needs of the cells in vitro . Most genes , however , show a compa - rable degree of expression . This might support the as - sumption that cells adapt very quickly when isolated and transferred into medium . If they would not , they could not replicate and survive . Within the large set of genes implied in cellular proliferation and identified by the GeneChip analysis we were especially interested in the analysis of TMSB10 . The ß - thymosins are a family of related peptides known to be present in a wide variety of mammalian and other vertebrate cells and tissues . TMSB10 mRNA is overexpressed in germ cell tumors of different histological types , breast - , ovarian - , uterine car - cinomas , colon , thyroid and esophageal carcinoma cell lines [ 13 , 21 , 22 ] . It has also been shown that TMSB10 plays a critical role in the regulation of anchorage - inde - pendent growth and assembly of actin filaments [ 23 ] . Fur - thermore upregulation of TMSB10 was identified in the breast cancer cell line MCF - 7 in the course of treatment with 5 - fluorouracil , tomudex and oxaliplatin , respective - ly . TMSB10 expression is also elevated in the 5 - fluoroura - cil - resistant colon cancer cell line H630R10 [ 24 ] implying a role for TMSB10 within the reaction of cells on toxic compounds . In conclusion we have reported for the first time the expression of TMSB10 in pancreatic carcinoma . TMSB10 might play a general role in human carcinogene - sis and in pancreatic carcinomas especially . Our finding that TMSB10 is strongly expressed in stroma cells of pan - creatic carcinoma supports the suggestion of Santelli et al . [ 23 ] who claim a critical role for TMSB10 in the regula - tion of anchorage - independent growth and assembly of actin filaments . Acknowledgments Thanks to Alfred E . Neuman whose comments were always appreciated and to Marit Biesold for technical assistance . This manuscript was supported by the Deutsche Krebshilfe ( 70 - 2937 - SaI ) . The data set of this study can be obtained from http : / / vtg . uniklini - kum - dresden . de / pankreaslabor . Gene Expression Analysis of Pancreatic Cell Lines Pancreatology 2005 ; 5 : 370−379 379 References 1 Jemal A , Murray T , Samuels A , Ghafoor A , Ward E , Thun MJ : Cancer statistics . CA Can - cer J Clin 2003 ; 53 : 5 – 26 . 2 Arbeitsgemeinschaft Bevölkerungsbezogener Krebsregister in Deutschland : Häufigkeiten und Trends . In Zusammenarbeit mit dem Ro - bert Koch Institut . Saarbrücken , 1999 . 3 Friess H , Ding J , Kleeff J , Liao Q , Berberat PO , Hammer J , Büchler MW : Identification of dis - ease - specific genes in chronic pancreatitis using DNA array technology . Ann Surg 2002 ; 234 : 769 – 779 . 4 van Hal NL , Vorst O , van Houwelingen AM , Kok EJ , Peijnenburg A , Aharoni A , van Tunen AJ , Keijer J : The application of DNA microar - rays in gene expression analysis . J Biotechnol 2000 ; 78 : 271 – 280 . 5 Han H , Bearss DJ , Browne LW , Calaluce R , Nagle RB , Hoff DDV : Identification of differ - entially expressed genes in pancreatic cancer cells using cDNA microarray . Cancer Res 2002 ; 62 : 2890 – 2896 . 6 Iacobuzio - Donahue CA , Maitra A , Shen - Ong GL , van Heek T , Ashfaq R , Meyer R , Walter K , Berg K , Hollingsworth MA , Cameron JL , Yeo CJ , Kern SE , Goggins M , Hruban RH : Discovery of novel tumor markers of pancreat - ic cancer using global gene expression technolo - gy . Am J Pathol 2002 ; 160 : 1239 – 1249 . 7 Iacobuzio - Donahue CA , Maitra A , Olsen M , Lowe AW , van Heek NT , Rosty C , Walter K , Sato N , Parker A , Ashfaq R , Jaffee E , Ryu B , Jones J , Eshleman JR , Yeo CJ , Cameron JL , Kern SE , Hruban RH , Brown PO , Goggins M : Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA mi - croarrays . Am J Pathol 2003 ; 162 : 1151 – 1162 . 8 Peiper M , Alldinger I , Heller R , Pilarsky C , Schumacher U , Knoefel WT , Heinecke A , Iz - bicki JR : Biological and molecular character - ization of a new human ampullary cancer cell line . Anticancer Res 2003 ; 23 : 291 – 298 . 9 Jesnowski R , Muller P , Schareck W , Liebe S , Löhr M : Immortalized pancreatic duct cells in vitro and in vivo . Ann NY Acad Sci 1999 ; 880 : 50 – 65 . 10 Grutzmann R , Pilarsky C , Staub E , Schmitt A , Foerder M , Specht T , Hinzmann B , Dahl E , Alldinger I , Rosenthal A , Ockert D , Saeger H : Systematic isolation of genes differentially ex - pressed in normal and cancerous tissue of the pancreas . Pancreatology 2003 ; 3 : 169 – 178 . 11 Schmitt AO , Specht T , Beckmann G , Dahl E , Pilarsky CP , Hinzmann B , Rosenthal A : Ex - haustive mining of EST libraries for genes dif - ferentially expressed in normal and tumour tis - sues . Nucleic Acids Res 1999 ; 27 : 4251 – 4260 . 12 Irizarry RA , Bolstad BM , Collin F , Cope LM , Hobbs B , Speed TP : Summaries of Affymetrix GeneChip probe level data . Nucleic Acids Res 2003 ; 31 : e15 . 13 Santelli G , Califano D , Chiappetta G , Vento M , Bartoli P , Zullo F , Trapasso F , Viglietto G , Fusco A : Thymosin beta - 10 gene overexpres - sion is a general event in human carcinogene - sis . Am J Pathol 1999 ; 155 : 799 – 804 . 14 Ghadimi BM , Schröck E , Walker RL , Wangsa D , Jauho A , Meltzer PS , Ried T : Specific chro - mosomal aberration and amplification of the AIB1 nuclear receptor coactivator gene in pan - creatic carcinomas . Am J Pathol 1999 ; 154 : 525 – 536 . 15 Grutzmann R , Foerder M , Alldinger I , Staub E , Brummendorf T , Ropcke S , Li X , Kristiansen G , Jesnowski R , Sipos B , Löhr M , Luttges J , Ockert D , Kloppel G , Saeger HD , Pilarsky C : Gene expression profiles of microdissected pancreatic ductal adenocarcinoma . Virchows Arch 2003 ; 443 : 508 – 517 . 16 Perl AK , Wilgenbus P , Dahl U , Semb H , Chris - tofori G : A causal role for E - cadherin in the transition from adenoma to carcinoma . Nature 1998 ; 392 : 190 – 193 . 17 Berx G , Becker KF , Hofler H , van Roy F : Mutations of the human E - cadherin ( CDH1 ) gene . Hum Mutat 1998 ; 12 : 226 – 237 . 18 Berx G , Cleton - Jansen AM , Nollet F , de Leeuw WJ , van de Vijver M , Cornelisse C , van Roy F : E - cadherin is a tumour / invasion suppressor gene mutated in human lobular breast cancers . EMBO J 1995 ; 14 : 6107 – 6115 . 19 Buchholz M , Biebl A , Neebetae A , Wagner M , Iwamura T , Leder G , Adler G , Gress TM : SER - PINE2 ( protease nexin I ) promotes extracellu - lar matrix production and local invasion of pancreatic tumors in vivo . Cancer Res 2003 ; 63 : 4945 – 4951 . 20 Sipos B , Moser S , Kalthoff H , Torok V , Löhr M , Kloppel G : A comprehensive characteriza - tion of pancreatic ductal carcinoma cell lines : Towards the establishment of an in vitro re - search platform . Virchows Arch 2003 ; 442 : 444 – 452 . 21 Viglietto G , Califano D , Bruni P , Baldassarre G , Vento MT , Belletti B , Fedele M , Santelli G , Boccia A , Manzo G , Santoro M , Fusco A : Reg - ulation of thymosin beta10 expression by TSH and other mitogenic signals in the thyroid gland and in cultured thyrocytes . Eur J Endo - crinol 1999 ; 140 : 597 – 607 . 22 Lee SH , Zhang W , Choi JJ , Cho YS , Lee SH , Kim JW , Hu L , Xu J , Liu J , Lee JH : Overex - pression of the thymosin beta - 10 gene in hu - man ovarian cancer cells disrupts F - actin stress fiber and leads to apoptosis . Oncogene 2001 ; 20 : 6700 – 6706 . 23 Santelli G , Bartoli PC , Giuliano A , Porcellini A , Mineo A , Barone MV , Busiello I , Trapasso F , Califano D , Fusco A : Thymosin beta - 10 pro - tein synthesis suppression reduces the growth of human thyroid carcinoma cells in semisolid medium . Thyroid 2002 ; 12 : 765 – 772 . 24 Maxwell PJ , Longley DB , Latif T , Boyer J , Al - len W , Lynch M , McDermott U , Harkin DP , Allegra CJ , Johnston PG : Identification of 5 - fluorouracil - inducible target genes using cDNA microarray profiling . Cancer Res 2003 ; 63 : 4602 – 4606 . 25 Ampe C , Vandekerckhove J , Klein HL , Cowan NJ : Prefoldin , a chaperone that delivers un - folded proteins to cytosolic chaperonin . Cell Calcium 1998 ; 93 : 863 – 873 . 26 Toutenhoofd SL , Strehler EE : Regulation of calmodulin mRNAs in differentiating human IMR - 32 neuroblastoma cells . Biochim Biophys Acta 2002 ; 1600 : 95 – 104 . 27 Behrens P , Brinkmann U , Wellmann A : CSE1L / CAS : Its role in proliferation and apop - tosis . Apoptosis 2003 ; 8 : 39 – 44 . 28 Witz IP : Differential expression of genes by tumor cells of a low or a high malignancy phe - notype : The case of murine and human Ly - 6 proteins . J Cell Biochem Suppl 2000 ; 34 : 61 – 66 . 29 Wolfel T , Hauer M , Schneider J , Serrano M , Wolfel C , Klehmann - Hieb E , De Plaen E , Han - keln T , Meyer zum Buschenfelde KH , Beach D : A p16INK4a - insensitive CDK4 mutant tar - geted by cytolytic T lymphocytes in a human melanoma . Science 1995 ; 269 : 1281 – 1284 . 30 Grutzmann R , Lüttges J , Sipos B , Dobrowolski F , Alldinger I , Kersting S , Ockert D , Koch R , Kalthoff H , Schackert HK , Kremer B , Saeger HD , Klöppel G , Pilarsky C : ADAM9 is a inde - pendent prognostic parameter of pancreatic ductal adenocarcinoma survival . Br J Cancer 2004 ; 90 : 1053 – 1058 . 31 Sato T , Saito H , Swensen J , Olifant A , Wood C , Danner D , Sakamoto T , Takita K , Kasumi F , Miki Y , Skolnick M , Nakamura Y : The human prohibitin gene located on chromosome 17q21 is mutated in sporadic breast cancer . Cancer Res 1992 ; 52 : 1643 – 1646 . 32 Wagner M , Klussmann JP , Fangmann R , Lin - der R , Elewa ME , Eidt S , Rose VM , Jungehuls - ing M , Schulze HJ : Cyclin - dependent kinase - inhibitor 1 ( CDKN1A ) in the squamous epi - thelium of the oropharynx : Possible implica - tions of molecular biology and compartmenta - tion . Anticancer Res 2001 ; 21 : 333 – 345 . 33 Menke A , Philippi C , Vogelmann R , Seidel B , Lutz MP , Adler G , Wedlich : Downregulation of E - cadherin expression by collagen type I and type III in pancreatic cancer cell lines . Cancer Res 2001 ; 61 : 3508 – 3517 . 34 Becker KF , Atkinson MJ , Reich U , Becker I , Nekarda H , Siewert JR and Hofler H : E - cad - herin gene mutations provide clues to diffuse type gastric carcinomas . Cancer Res 1994 ; 54 : 3845 – 3852 .